Performance reporting through clear and timely information
Enabling better health care while creating a sustained and growing investment opportunity.
If you invest or are considering investing in TSO3, you will want to keep current with the Company’s performance and understand any fluctuations. TSO3’s online Investor Relations section keeps you up-to-date with the latest in financial reporting, including annual reports, quarterly results, and conference call webcasts. As an investment, TSO3 builds value in the health care market through rapid research prototyping. A leading innovator in low-temperature sterilization technology, TSO3 also partners with developers in creating next-generation medical devices to ensure sterilization for these devices will be viable.
|Investor News||Investor Events|
|March 19, 2018: TSO3 Submits Response to US Regulators in Support of Terminal Sterilization of Duodenoscopes||February 22, 2018: RBC Capital Markets 2018 Healthcare Conference|
|March 14, 2018: TSO3’s STERIZONE® VP4 Sterilizer Receives 510(k) Clearance||November 06, 2017: Replay the webcast Third Quarter 2017 Results|
|March 07, 2018: TSO3 Sets Fourth Quarter and Full Year 2017 Earnings Call for Wednesday, March 21, 2018 at 8:30 a.m. EDT|